ALK-Abello A/S 2005 AR2
The report details Chr. Hansen Group's transitional 2004/05 financial year, highlighted by the divestment of its Food Ingredients Sector to PAI partners for DKK 8.2 billion, resulting in a gain of DKK 4.2 billion. Following this divestment, the company announced plans to merge Chr. Hansen Holding A/S with ALK-Abelló A/S, shifting its core focus entirely to allergy vaccines. ALK-Abelló achieved 15% organic growth in revenue, driven by strong sales of its injection-based and drop-based vaccines, and advanced its pipeline with clinical trials for the grass pollen allergy tablet GRAZAX. Additionally, the company initiated a cross-organizational safety, health, and environment (SHE) management system structured on ISO 14001 and OHSAS 18001 guidelines.
Company: ALK-Abello A/S
Sector: Manufacturing
Country: Denmark
Year: 2005
Type: AR2
Pages: 68
Back to company
ALK-Abello A/S
Annual Report
The report details Chr. Hansen Group's transitional 2004/05 financial year, highlighted by the divestment of its Food Ingredients Sector to PAI partners for DKK 8.2 billion, resulting in a gain of DKK 4.2 billion. Following this divestment, the company announced plans to merge Chr. Hansen Holding A/S with ALK-Abelló A/S, shifting its core focus entirely to allergy vaccines. ALK-Abelló achieved 15% organic growth in revenue, driven by strong sales of its injection-based and drop-based vaccines, and advanced its pipeline with clinical trials for the grass pollen allergy tablet GRAZAX. Additionally, the company initiated a cross-organizational safety, health, and environment (SHE) management system structured on ISO 14001 and OHSAS 18001 guidelines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2005
Reporting Period
Sep 1, 2004 - Aug 31, 2005
Fiscal Year
2005
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees